Health
Johnson & Johnson Vaccine Might Save the Company – Live Trading News
Johnson & Johnson Vaccine Might Save the Company Headline News
US health care giant Johnson & Johnson, beset by recent scandals over talcum powder and the opioid crisis, is poised for a reputational lift with its pathbreaking coronavirus vaccine.
J & J, which has vowed to sell the vaccine at cost, won approval Thursday from the European Union for its Covid-19 jab after receiving the green light earlier from regulators in the United States, Canada and South Africa.
The J & J inoculation is the first approved by health authorities to require just one shot, the…
-
General21 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News18 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News17 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General14 hours agoQantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers